Abstract:Background: Previous study reveals that, exogenous bone marrow mesenchymal stem cells (MSCs) may settle down in kidney and differentiate into renal cells, as well as participate in the repair of injured renal tissues. However, the repairing pathway is unclear. Objective: To investigate the potential effect of exogenous MSCs transplantation on renal injury. Design, time and setting: An in vivo trial of cytology was performed in the Urinary Surgery Institute of Nanchang University (Nanchang, Jiangxi, China) from March to September in 2007. Materials: Fifty-six SD rats of clean grade were recruited. Eight male rats of them were used to prepare MSCs, while other 48 female rats were divided into three groups at random, namely cell transplantation group, model control group and sham group. Each group contained 16 rats. Fluorochrome DAPI was a product of Biotium Inc. Ricinus communis agglutinin was produced by Vector Laboratories. BrdU was offered by Sigma. Methods: Bone marrow-derived MSCs were collected from male SD rats, then isolated by Percoll density gradient centrifugation and labeled with DAPI at a density of 1.5 × 1010/L. Renal injury models induced by ischemia and reperfusion were created in cell transplantation group and model control, while renal vessels were not ligated in the sham group. SD rats were subjected to clamping renal pedicles for 45 minutes. DAPI-labeled MSCs or 1 mL saline were transplanted into the rats by inferior vena cava in cell transplantation group or model control group and sham group. All animals received daily injection of BrdU, then blood and renal tissues were sampled. Main outcome measures: Immunohistochemical methods and fluorescence microscope were performed to identify transplanted MSCs and BrdU in renal tissues. To confirm if the MSCs may differentiate into renal tubular cells, ricinus communis agglutinin that binds specifically to the luminal surface of tubules was used. Biochemistry methods were used to detect the levels of creatinine and blood urea nitrogen in serum. Results: At day 3 after transplantation, the DAPI-positive cells were few, but obviously increased at day 4 (P < 0.05). Most of DAPI-labeled cells could express ricinus communis agglutinin-positive cells simultaneously and were mainly distributed in the renal tubule. There were few positive cells in renal cortex and kidney inner medullary, even absent in renal glomerulus. In sham group, the renal tissue cells proliferated slowly, and BrdU-positive cells were remarkably lower than that in model control group at day 4 (P < 0.05); BrdU-positive cells were distributed identically with DAPI-positive cells in the cell transplantation and model control groups at days 2, 3 and 4, but the BrdU-positive cells in transplantation group were much more than that of the control group (P < 0.05) Compared with the model control group, the serum level of blood urea nitrogen in cell transplantation group was significantly decreased at days 1 and 2 (P < 0.05), and the serum levels of creatinine were significantly lower at days 1, 2 and 3 (P < 0.05). Conclusion: Exogenous MSCs can migrate and repopulate in the ischemically injured kidney, differentiate into renal tubular cells and promote cells proliferation to repair renal injury. MSCs have depressant effect on increasing degrees of blood urea nitrogen and creatinine at early stage, this protective effect has no association with location and differentiation of MSCs.

Therapeutic Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells Against Acute Tubular Necrosis Quantified Through Measures of Inos, BMP-7 and Bcl-2

Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions.

Nephroprotective Effects of Subcapsular Transplantation of Metanephric Mesenchymal Cells on Gentamicin-Induced Acute Tubular Necrosis in Rats

Effect of Stem Cell Factor and Granulocyte-Macrophage Colony-Stimulating Factor-Induced Bone Marrow Stem Cell Mobilization on Recovery from Acute Tubular Necrosis in Rats

Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury

Human Umbilical Cord-Derived Mesenchymal Stem Cells and Human Cord Blood Mononuclear Cells Protect Against Cisplatin-Induced Acute Kidney Injury in Rat Models.

Bone Marrow Mesenchymal Stem Cells Ameliorate Rat Acute Renal Failure by Differentiation into Renal Tubular Epithelial-Like Cells.

Human umbilical cord mesenchymal stem cell attenuates renal fibrosis via TGF-β/Smad signaling pathways in vivo and in vitro

[Magnetic Resonance Imaging of Mesenchymal Stem Cells Transplanted Intravascularly in Treatment of Acute Renal Failure:In Vivo Experiment with Rats].

Experiment of Transplanting Metanephric Mesenchymal Stem Cells to Repair the Renal Function of Acute Tubular Necrosis Model

Enhanced Renoprotective Effect of IGF-1 Modified Human Umbilical Cord-Derived Mesenchymal Stem Cells on Gentamicin-Induced Acute Kidney Injury

Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Nephrocyte Injury and Proteinuria in a Diabetic Nephropathy Rat Model

The Effect of Mesenchymal Stromal Cells on Doxorubicin-Induced Nephropathy in Rats

Effects of umbilical cord mesenchymal stem cells on regulating renal inflammatory microenvironment of kidney in mice with acute kidney injury

Mesenchymal stem cells transplantation attenuates hyperuricemic nephropathy in rats

Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4/NF-κB signaling pathway in vivo and in vitro

Bone marrow-derived mesenchymal stem cells attenuate tubulointerstitial injury through multiple mechanisms in UUO model.

Human Umbilical Cord Blood Mononuclear Cells Protect Against Renal Tubulointerstitial Fibrosis in Cisplatin-Treated Rats.

The Renoprotective and Anti-Inflammatory Effects of Human Urine-Derived Stem Cells on Acute Kidney Injury Animals

Bone marrow mesenchymal stem cells transplantation for the repair of renal injury

Mesenchymal Stem Cells Ameliorate Uric Acid Induced Nephropathy in Rats